| Kreitman RJ, Margulies I, Stetler-Stevenson M, et al.
Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias. [Journal Article]
Clin Cancer Res 2000 Apr; 6(4):1476-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Salvatore G, Beers R, Margulies I, et al.
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display. [Journal Article]
Clin Cancer Res 2002 Apr; 8(4):995-1002.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Kreitman RJ, Wang QC, FitzGerald DJ, et al.
Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. [Journal Article]
Int J Cancer 1999 Mar 31; 81(1):148-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Mansfield E, Amlot P, Pastan I, et al.
Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors. [Journal Article]
Blood 1997 Sep 1; 90(5):2020-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Mansfield E, Pastan I, FitzGerald DJ
Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies. [Journal Article]
Bioconjug Chem 1996 Sep-Oct; 7(5):557-63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Bang S, Nagata S, Onda M, et al.
HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity. [Journal Article]
Clin Cancer Res 2005 Feb 15; 11(4):1545-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Shen GL, Li JL, Ghetie MA, et al.
Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas. [Journal Article]
Int J Cancer 1988 Nov 15; 42(5):792-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Keppler-Hafkemeyer A, Kreitman RJ, Pastan I
Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies. [Journal Article]
Int J Cancer 2000 Jul 1; 87(1):86-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Frankel AE
Increased sophistication of immunotoxins. [Comment, Editorial]
Clin Cancer Res 2002 Apr; 8(4):942-4.
Full Citation | Find Related Articles |
  |
